Segment Information (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2025 USD ($) segment	Jun. 30, 2024 USD ($)
Segment Reporting [Abstract]
Number of operating segments | segment			1
Number of reportable segments | segment			1
Segment Reporting Information [Line Items]
Total research and development expenses	$ 50,614	$ 61,625	$ 111,343	$ 116,270
Total selling, general, and administrative expenses	71,038	79,710	134,460	148,904
Reportable Segment
Segment Reporting Information [Line Items]
Personnel compensation and related costs	22,447	31,209	46,527	59,217
Licensing fees	0	0	19,997	0
CROs/CMOs/Investigators expenses	19,935	24,305	29,765	44,209
Other costs	8,232	6,111	15,054	12,844
Total research and development expenses	50,614	61,625	111,343	116,270
Clinical programs	16,967	21,348	45,059	40,136
Pre-Clinical programs	5,069	3,139	8,383	5,188
Unallocated research and development expenses	28,578	37,138	57,901	70,946
Total selling, general, and administrative expenses	71,038	79,710	134,460	148,904
Selling and marketing expenses	46,764	53,275	88,703	96,869
General and administrative expenses	24,274	26,435	45,757	52,035
Reportable Segment | Selling, general and administrative
Segment Reporting Information [Line Items]
Personnel compensation and related costs	42,679	48,279	83,322	94,173
Other costs	$ 28,359	$ 31,431	$ 51,138	$ 54,731